Brief: Advaxis Announces Pricing Of $10.5 Mln Registered Direct Offering
21/01/2020 15:33
Jan 21 (Reuters) - Advaxis Inc ADXS.O :
* ADVAXIS, INC. ANNOUNCES PRICING OF $10.5 MILLION
REGISTERED
DIRECT OFFERING
* ADVAXIS INC - AGREEMENT WITH TWO INSTITUTIONAL INVESTORS
FOR
PURCHASE AND SALE OF 10 MILLION SHARES OF CO'S COMMON STOCK AT
$1.05 PER SHARE
Source text for Eikon: ID:nGNX523MNk
Further company coverage: ADXS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ayala Pharmaceuticals
See all newsBrief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
Immunome slides on $200 mln equity offering
Immunome edges up after $200 mln equity offering
Brief: Immunome To Acquire AL102 Phase 3 Asset for the Treatment of Desmoid Tumors From Ayala Pharmaceuticals
Brief: Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors